202 related articles for article (PubMed ID: 19439303)
1. Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study.
Momiyama Y; Kawaguchi A; Kajiwara I; Ohmori R; Okada K; Saito I; Konishi M; Nakamura M; Sato S; Kokubo Y; Mannami T; Adachi H; Kario K; Iso H; Ohsuzu F; Tsushima M
Atherosclerosis; 2009 Nov; 207(1):272-6. PubMed ID: 19439303
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.
Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF
J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis from the MultiEthnic Study of Atherosclerosis.
McEvoy JW; Blaha MJ; DeFilippis AP; Lima JA; Bluemke DA; Hundley WG; Min JK; Shaw LJ; Lloyd-Jones DM; Barr RG; Budoff MJ; Blumenthal RS; Nasir K
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):700-9. PubMed ID: 25573855
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein.
Leu HB; Lin CP; Lin WT; Wu TC; Chen JW
Chest; 2004 Oct; 126(4):1032-9. PubMed ID: 15486359
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure.
Jug B; Salobir BG; Vene N; Sebestjen M; Sabovic M; Keber I
Heart Vessels; 2009 Jul; 24(4):271-6. PubMed ID: 19626399
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of High-Sensitivity C-Reactive Protein in Patients with Preserved Renal Function Following Percutaneous Coronary Intervention.
Shimizu T; Suwa S; Dohi T; Wada H; Miyauchi K; Shitara J; Endo H; Doi S; Ogita M; Kasai T; Okazaki S; Isoda K; Daida H
Int Heart J; 2019 Sep; 60(5):1037-1042. PubMed ID: 31484863
[TBL] [Abstract][Full Text] [Related]
8. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study.
Cui C; Liu L; Qi Y; Han N; Xu H; Wang Z; Shang X; Han T; Zha Y; Wei X; Wu Z
Cardiovasc Diabetol; 2024 May; 23(1):156. PubMed ID: 38715129
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.
Held C; White HD; Stewart RAH; Budaj A; Cannon CP; Hochman JS; Koenig W; Siegbahn A; Steg PG; Soffer J; Weaver WD; Östlund O; Wallentin L;
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066452
[TBL] [Abstract][Full Text] [Related]
10. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study.
Muhlestein JB; May HT; Galenko O; Knowlton KU; Otvos JD; Connelly MA; Lappe DL; Anderson JL
Am Heart J; 2018 Aug; 202():27-32. PubMed ID: 29803983
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Biochemical Markers on Major Adverse Cardiovascular Events and Contralateral Carotid Artery Stenosis Progression Following Carotid Interventions.
Stone PA; Thompson SN; Khan M; Northfield E; Schillinger R; Skaff P
Ann Vasc Surg; 2017 Jan; 38():144-150. PubMed ID: 27546852
[TBL] [Abstract][Full Text] [Related]
12. Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in high-risk patients.
Okazaki S; Furukado S; Abe Y; Tanaka M; Miwa K; Yamagami H; Sakaguchi M; Sakoda S; Kitagawa K
Cerebrovasc Dis; 2010; 30(2):180-7. PubMed ID: 20588013
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
14. Plasma interleukin-27 levels in patients with coronary artery disease.
Miura K; Saita E; Suzuki-Sugihara N; Miyata K; Ikemura N; Ohmori R; Ikegami Y; Kishimoto Y; Kondo K; Momiyama Y
Medicine (Baltimore); 2017 Oct; 96(43):e8260. PubMed ID: 29068992
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and Cholesterol Risk in the FOURIER Trial.
Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS
Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884
[TBL] [Abstract][Full Text] [Related]
16. The clinical role of combined serum C1q and hsCRP in predicting coronary artery disease.
Jia Y; Wen W; Yang Y; Huang M; Ning Y; Jiao X; Liu S; Qin Y; Zhang M
Clin Biochem; 2021 Jul; 93():50-58. PubMed ID: 33861985
[TBL] [Abstract][Full Text] [Related]
17. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study.
Saito I; Sato S; Nakamura M; Kokubo Y; Mannami T; Adachi H; Konishi M; Okada K; Iso H; Kario K; Ohsuzu F; Momiyama Y; Tsushima M
Atherosclerosis; 2007 Sep; 194(1):238-44. PubMed ID: 16963054
[TBL] [Abstract][Full Text] [Related]
18. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1.
Ishikawa J; Tamura Y; Hoshide S; Eguchi K; Ishikawa S; Shimada K; Kario K
Stroke; 2007 Mar; 38(3):911-7. PubMed ID: 17272770
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease.
Ishii H; Kumada Y; Toriyama T; Aoyama T; Takahashi H; Murohara T
J Vasc Surg; 2010 Oct; 52(4):854-9. PubMed ID: 20638228
[TBL] [Abstract][Full Text] [Related]
20. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population.
Makita S; Nakamura M; Satoh K; Tanaka F; Onoda T; Kawamura K; Ohsawa M; Tanno K; Itai K; Sakata K; Okayama A; Terayama Y; Yoshida Y; Ogawa A
Atherosclerosis; 2009 May; 204(1):234-8. PubMed ID: 18790479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
